NAPOLI‑3 trial design and dosing details

John outlines the trial arms, specific drug doses in nalirifox, and differences from prior irinotecan formulations.

Play episode from 02:56

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!